The goal of DDT’s global projects is to reduce the global burden of diabetes by working with international partners. To achieve this goal, DDT contributes technical skills and resources to international or national organizations and public health agencies in other countries. These efforts support research and programs related to the prevention and control of diabetes in these countries.
Overall Objective: Diabetes imposes a large financial burden on national health care systems worldwide. Quantifying this burden for individual countries, different regions of the world, and the world as a whole can help researchers and public officials monitor changes over time. It also helps them assess the effect of their efforts to prevent and manage diabetes at national, regional, and international levels. The primary objective of this project is to estimate health care expenditures associated with diabetes by country, by region, and for the world.
- Zhang P, Zhang X, Brown J, et al. Global healthcare expenditure on diabetes for 2010 and 2030external icon. Diabetes Res Clin Pract. 2010;87(3):293–301. doi: 10.1016/j.diabres.2010.01.026.
- International Diabetes Federation. IDF Diabetes Atlas, 7th Edition. Brussels, Belgium: International Diabetes Federation; 2015.
Collaborative Research in Diabetes Epidemiology and Economics with National Originations-Public Research Institutes in Other Countries
Overall Objective: This project is designed to provide technical skills and resources to support diabetes epidemiology and economics research that is mutually beneficial to DDT and to DDT’s partners in other countries, especially in developing countries.
- Chinese Centers for Disease Control and Prevention, China-Japan Friendship Hospital, Da Qing General Hospital, China
- Federal University of Rio Grande do Sul, Brazil
- German Center for Diabetes Research, Germany
- Li G, Zhang P, Wang J, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up studyexternal icon. Lancet. 2008;371(9626):1783–1789. doi: 10.1016/S0140-6736(08)60766-7.
- Li G, Zhang P, Wang J, et al. Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up studyexternal icon. Lancet Diabetes Endocrinol. 2014;2:474–480.
- Q Gong, EW Gregg, J Wang, et al. Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study 2010external icon. Diabetologia (2011) 54: 300. doi:10.1007/s00125-010-1948-9
- Q Gong, P Zhang, J Wang, et al. Changes in mortality in people with IGT before and after the onset of diabetes during the 23-year follow-up of the Da Qing Diabetes Prevention Studyexternal icon. Diabetes Care. 2016;39(9)1550–1555.